Synthetic Protein Scaffolds Based on Peptide Motifs and Cognate Adaptor Domains for Improving Metabolic Productivity

The efficiency of many cellular processes relies on the defined interaction among different proteins within the same metabolic or signaling pathway. Consequently, a spatial colocalization of functionally interacting proteins has frequently emerged during evolution. This concept has been adapted within the synthetic biology community for the purpose of creating artificial scaffolds. A recent advancement of this concept is the use of peptide motifs and their cognate adaptor domains. SH2, SH3, GBD, and PDZ domains have been used most often in research studies to date. The approach has been successfully applied to the synthesis of a variety of target molecules including catechin, D-glucaric acid, H2, hydrochinone, resveratrol, butyrate, gamma-aminobutyric acid, and mevalonate. Increased production levels of up to 77-fold have been observed compared to non-scaffolded systems. A recent extension of this concept is the creation of a covalent linkage between peptide motifs and adaptor domains, which leads to a more stable association of the scaffolded systems and thus bears the potential to further enhance metabolic productivity.

[1]  Thomas H Segall-Shapiro,et al.  Creation of a Bacterial Cell Controlled by a Chemically Synthesized Genome , 2010, Science.

[2]  Tae Seok Moon,et al.  Use of modular, synthetic scaffolds for improved production of glucaric acid in engineered E. coli. , 2010, Metabolic engineering.

[3]  Amos Bairoch,et al.  Recent improvements to the PROSITE database , 2004, Nucleic Acids Res..

[4]  Michael K. Rosen,et al.  Autoinhibition and activation mechanisms of the Wiskott–Aldrich syndrome protein , 2000, Nature.

[5]  B. Mayer,et al.  SH3 domains: complexity in moderation. , 2001, Journal of cell science.

[6]  B. Thompson,et al.  Structures of the human Pals1 PDZ domain with and without ligand suggest gated access of Crb to the PDZ peptide-binding groove , 2015, Acta crystallographica. Section D, Biological crystallography.

[7]  Mark Howarth,et al.  Structural analysis and optimization of the covalent association between SpyCatcher and a peptide Tag. , 2014, Journal of molecular biology.

[8]  J. Tait,et al.  Challenges and opportunities. , 1996, Journal of psychiatric and mental health nursing.

[9]  Jaap Heringa,et al.  An analysis of protein domain linkers: their classification and role in protein folding. , 2002, Protein engineering.

[10]  P. Permi,et al.  SH3 domain ligand binding: What's the consensus and where's the specificity? , 2012, FEBS letters.

[11]  Timothy S. Ham,et al.  Production of the antimalarial drug precursor artemisinic acid in engineered yeast , 2006, Nature.

[12]  Ignacio E. Sánchez,et al.  The eukaryotic linear motif resource ELM: 10 years and counting , 2013, Nucleic Acids Res..

[13]  Wei-Chiang Shen,et al.  Insertion of the Designed Helical Linker Led to Increased Expression of Tf-Based Fusion Proteins , 2009, Pharmaceutical Research.

[14]  Tae Seok Moon,et al.  Production of Glucaric Acid from a Synthetic Pathway in Recombinant Escherichia coli , 2009, Applied and Environmental Microbiology.

[15]  B. Zakeri,et al.  Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin , 2012, Proceedings of the National Academy of Sciences.

[16]  Welch Gr,et al.  Enzyme Organization in the Polyaromatic—Biosynthetic Pathway: The arom Conjugate and Other Multienzyme Systems* , 1980 .

[17]  E. Baker,et al.  Autocatalytically generated Thr-Gln ester bond cross-links stabilize the repetitive Ig-domain shaft of a bacterial cell surface adhesin , 2013, Proceedings of the National Academy of Sciences.

[18]  R. Bruccoleri,et al.  Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Carroll,et al.  Evolution at Two Levels: On Genes and Form , 2005, PLoS biology.

[20]  Zhilei Chen,et al.  Two-component protein hydrogels assembled using an engineered disulfide-forming protein-ligand pair. , 2013, Biomacromolecules.

[21]  Wei-Chiang Shen,et al.  Fusion protein linkers: property, design and functionality. , 2013, Advanced drug delivery reviews.

[22]  Jiang Xia,et al.  Affinity-guided covalent conjugation reactions based on PDZ-peptide and SH3-peptide interactions. , 2014, Bioconjugate chemistry.

[23]  Toby J Gibson,et al.  Patterns and clusters within the PSM column in TiBS, 1992-2004. , 2004, Trends in biochemical sciences.

[24]  Yun Bai,et al.  Improving the Oral Efficacy of Recombinant Granulocyte Colony-Stimulating Factor and Transferrin Fusion Protein by Spacer Optimization , 2006, Pharmaceutical Research.

[25]  Zhengtao Wang,et al.  Improvement of catechin production in Escherichia coli through combinatorial metabolic engineering. , 2015, Metabolic engineering.

[26]  Hui-Chun Cheng,et al.  Structural mechanism of WASP activation by the enterohaemorrhagic E. coli effector EspFU , 2008, Nature.

[27]  Y. Okada,et al.  Production of enkephalin in tobacco protoplasts using tobacco mosaic virus RNA vector , 1990, FEBS letters.

[28]  S. Hong,et al.  Efficient gamma-aminobutyric acid bioconversion by employing synthetic complex between glutamate decarboxylase and glutamate/GABA antiporter in engineered Escherichia coli , 2013, Journal of Industrial Microbiology & Biotechnology.

[29]  J Ovádi,et al.  Substrate channeling. , 1999, Methods.

[30]  R. Sauer,et al.  Optimizing the stability of single-chain proteins by linker length and composition mutagenesis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P Argos,et al.  An investigation of oligopeptides linking domains in protein tertiary structures and possible candidates for general gene fusion. , 1990, Journal of molecular biology.

[32]  K. Peter,et al.  Single-chain antibodies as diagnostic tools and therapeutic agents , 2009, Thrombosis and Haemostasis.

[33]  M. Oh,et al.  Butyrate production in engineered Escherichia coli with synthetic scaffolds. , 2013, Biotechnology and bioengineering.

[34]  M. Oda,et al.  High Resolution Crystal Structure of the Grb2 SH2 Domain with a Phosphopeptide Derived from CD28 , 2013, PloS one.

[35]  J. Keasling,et al.  Engineering a mevalonate pathway in Escherichia coli for production of terpenoids , 2003, Nature Biotechnology.

[36]  M. Feng,et al.  Bifunctional enhancement of a β-glucanase-xylanase fusion enzyme by optimization of peptide linkers , 2008, Applied Microbiology and Biotechnology.

[37]  Daisuke Tsuchiya,et al.  Structural basis for channelling mechanism of a fatty acid β‐oxidation multienzyme complex , 2004, The EMBO journal.

[38]  K. Siminovitch,et al.  Structure of Cdc42 in complex with the GTPase-binding domain of the ‘Wiskott–Aldrich syndrome’ protein , 1999, Nature.

[39]  Jeffrey D Varner,et al.  Engineering the spatial organization of metabolic enzymes: mimicking nature's synergy. , 2008, Current opinion in biotechnology.

[40]  R. Kwok Five hard truths for synthetic biology , 2010, Nature.

[41]  L. Cantley,et al.  Recognition of Unique Carboxyl-Terminal Motifs by Distinct PDZ Domains , 1997, Science.

[42]  Kirsten Jørgensen,et al.  Metabolon formation and metabolic channeling in the biosynthesis of plant natural products. , 2005, Current opinion in plant biology.

[43]  Jens Schneider-Mergener,et al.  Journal speciation , 1998, Nature Structural Biology.

[44]  Gabriel C. Wu,et al.  Synthetic protein scaffolds provide modular control over metabolic flux , 2009, Nature Biotechnology.

[45]  Chong Xue,et al.  Increasing the homogeneity, stability and activity of human serum albumin and interferon-alpha2b fusion protein by linker engineering. , 2008, Protein expression and purification.

[46]  Huimin Zhao,et al.  Challenges and opportunities in synthetic biology for chemical engineers. , 2013, Chemical engineering science.

[47]  E. W. Miles,et al.  The Molecular Basis of Substrate Channeling* , 1999, The Journal of Biological Chemistry.

[48]  Oliver Yu,et al.  Synthetic scaffolds increased resveratrol biosynthesis in engineered yeast cells. , 2012, Journal of biotechnology.

[49]  Daniel C. Ducat,et al.  Insulation of a synthetic hydrogen metabolism circuit in bacteria , 2010, Journal of biological engineering.

[50]  Kazuya Machida,et al.  The SH2 domain: versatile signaling module and pharmaceutical target. , 2005, Biochimica et biophysica acta.

[51]  T Pawson,et al.  SH2 domains, interaction modules and cellular wiring. , 2001, Trends in cell biology.

[52]  Jing Li,et al.  Rate Enhancement of an Interfacial Biochemical Reaction through Localization of Substrate and Enzyme by an Adaptor Domain , 2010, The journal of physical chemistry. B.

[53]  J. H. Shinn,et al.  Minimotif Miner: a tool for investigating protein function , 2006, Nature Methods.

[54]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[55]  Bijan Zakeri,et al.  Superglue from bacteria: unbreakable bridges for protein nanotechnology. , 2014, Trends in biotechnology.

[56]  C. Nakamura,et al.  Metabolic engineering for the microbial production of 1,3-propanediol. , 2003, Current opinion in biotechnology.

[57]  W. Lim,et al.  Domains, motifs, and scaffolds: the role of modular interactions in the evolution and wiring of cell signaling circuits. , 2006, Annual review of biochemistry.

[58]  W. Lim,et al.  Mechanism and role of PDZ domains in signaling complex assembly. , 2001, Journal of cell science.

[59]  Blaine A. Pfeifer,et al.  Biosynthesis of Polyketides in Heterologous Hosts , 2001, Microbiology and Molecular Biology Reviews.

[60]  T Pawson,et al.  SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. , 1991, Science.

[61]  M. Howarth,et al.  SpyLigase peptide–peptide ligation polymerizes affibodies to enhance magnetic cancer cell capture , 2014, Proceedings of the National Academy of Sciences.

[62]  Yuri Gleba,et al.  Immunoabsorbent nanoparticles based on a tobamovirus displaying protein A , 2006, Proceedings of the National Academy of Sciences.

[63]  Heinrich Sticht,et al.  Structural investigation of the binding of a herpesviral protein to the SH3 domain of tyrosine kinase Lck. , 2002, Biochemistry.